https://www.selleckchem.com/products/atn-161.html
The insulin-treated group demonstrated significantly reduced changes in white matter hyperintensity volume in deep and frontal regions after 12 months, with a similar trend for global volume. White matter hyperintensity volume progression correlated with worsened Alzheimer's disease cerebral spinal fluid biomarker profile and cognitive function; however, patterns of correlations differed by treatment group. Intranasal insulin treatment for 12 months reduced white matter hyperintensity volume progression and supports insulin's potential
Like
Comment
Share
